1x | | genetski polimorfizmi, personalized medicine, CYP2D6, clinical-pharmacogenetic models, ABCC2, ABCB1, genetic polymorphisms, UGT2B7, Parkinson's disease, sopojavna duševna simptomatika, odvisnost, lajšanje bolečine, alkohol, dopaminergic treatment, pharmacogenetics, adverse events |